Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by NOVARTIS PHARMS CORP

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
020007 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020103 New Drug Application Approval New formulation (P) Priority review drug
020605 New Drug Application Approval New manufacturer (S) Standard review drug
020671 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020781 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
020981 New Drug Application Approval New formulation (P) Priority review drug
021877 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
022059 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
022291 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
022465 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
125504 Biologic License Application Approval
202806 New Drug Application Approval New molecular entity (NME) (S) Standard review drug (V) Orphan drug
203255 New Drug Application Approval New manufacturer (S) Standard review drug
204114 New Drug Application Approval New molecular entity (NME) (S) Standard review drug (V) Orphan drug
205266 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
205353 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
205755 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
206910 New Drug Application Approval New manufacturer (P) Priority review drug
207027 New Drug Application Approval New formulation (P) Priority review drug
207620 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
207923 New Drug Application Approval New formulation (S) Standard review drug
207930 New Drug Application Approval New combination (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval